Chromatin remodeler HELLS is an epigenetic driver for hepatocellular carcinoma progression

被引：1
|
作者：
Law, Cheuk-Ting
Wei, Larry L.
Tsang, Felice H. C.
Xu, Iris M. J.
Lai, Robin K. H.
Ho, Daniel W. H.
Lee, Joyce M. F.
Wong, Carmen C. L.
Ng, Irene O. L.
Wong, Jack C. M.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-1022
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1022
引用
收藏
页数：2
相关论文
共 50 条
  • [41] HELLS, a chromatin remodeler is highly expressed in pancreatic cancer and downregulation of it impairs tumor growth and sensitizes to cisplatin by reexpressing the tumor suppressor TGFBR3
    Hou, Xuyang
    Yang, Leping
    Wang, Kunpeng
    Zhou, Yan
    Li, Qinglong
    Kong, Fanhua
    Liu, Xi
    He, Jun
    CANCER MEDICINE, 2021, 10 (01): : 350 - 364
  • [42] Uridine phosphorylase 1-associated metabolic reprogramming as a driver of immune evasion and progression of hepatocellular carcinoma
    Schuler, Pia
    Ortmayr, Gregor
    Hillinger, Theresa
    Aumer, Florian
    Starlinger, Patrick
    Gruenberger, Thomas
    Chen, Doris
    Mikulitis, Wolfgang
    INNERE MEDIZIN, 2024, 65 : S109 - S110
  • [43] Chromatin-associated OGT promotes the malignant progression of hepatocellular carcinoma by activating ZNF263
    Wang, Lingyan
    Li, Guofang
    Zhou, Ziyu
    Ge, Chang
    Chen, Qiushi
    Liu, Yajie
    Zhang, Nana
    Zhang, Keren
    Niu, Mingshan
    Li, Wenli
    Zhong, Xiaomin
    Wu, Sijin
    Zhang, Jianing
    Liu, Yubo
    ONCOGENE, 2023, 42 (30) : 2329 - 2346
  • [44] Chromatin-associated OGT promotes the malignant progression of hepatocellular carcinoma by activating ZNF263
    Lingyan Wang
    Guofang Li
    Ziyu Zhou
    Chang Ge
    Qiushi Chen
    Yajie Liu
    Nana Zhang
    Keren Zhang
    Mingshan Niu
    Wenli Li
    Xiaomin Zhong
    Sijin Wu
    Jianing Zhang
    Yubo Liu
    Oncogene, 2023, 42 : 2329 - 2346
  • [45] Cellular Senescence in Hepatocellular Carcinoma: The Passenger or the Driver?
    Cai, Xiurong
    Guillot, Adrien
    Liu, Hanyang
    CELLS, 2023, 12 (01)
  • [46] Chromatin remodeler ALC1 prevents replication-fork collapse by slowing fork progression
    Ooka, Masato
    Abe, Takuya
    Cho, Kosai
    Koike, Kaoru
    Takeda, Shunichi
    Hirota, Kouji
    PLOS ONE, 2018, 13 (02):
  • [47] Targeting p300/CBP Attenuates Hepatocellular Carcinoma Progression through Epigenetic Regulation of Metabolism
    Cai, Ling-Yan
    Chen, Shi-Jie
    Xiao, Sen-Hao
    Sun, Qin-Juan
    Ding, Chen-Hong
    Zheng, Bai-Nan
    Zhu, Xin-Yan
    Liu, Shu-Qing
    Yang, Feng
    Yang, Ya-Xi
    Zhou, Bing
    Luo, Cheng
    Zhang, Xin
    Xie, Wei-Fen
    CANCER RESEARCH, 2021, 81 (04) : 860 - 872
  • [48] Epigenetic instability and chromosomal instability in hepatocellular carcinoma
    Katoh, H
    Shilbata, T
    Kokubu, A
    Ojima, H
    Fukayama, M
    Kanai, Y
    Hirohashi, S
    AMERICAN JOURNAL OF PATHOLOGY, 2006, 168 (04): : 1375 - 1384
  • [49] Epigenetic therapy as a novel approach in hepatocellular carcinoma
    Anestopoulos, Ioannis
    Voulgaridou, Georgia Persephoni
    Georgakilas, Alexandros G.
    Franco, Rodrigo
    Pappa, Aglaia
    Panayiotidis, Mihalis I.
    PHARMACOLOGY & THERAPEUTICS, 2015, 145 : 103 - 119
  • [50] Epigenetic modulation enhances immunotherapy for hepatocellular carcinoma
    Hong, Young K.
    Li, Yan
    Pandit, Harshul
    Li, SuPing
    Pulliam, Zachary
    Zheng, Qianqian
    Yu, Youxi
    Martin, Robert C. G.
    CELLULAR IMMUNOLOGY, 2019, 336 : 66 - 74
12345